Cipher net income drops 32% to US$ 4 juta in Q2 FY26; revenue falls 10% to US$ 12,1 juta

Reuters2026/08/11 21:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Cipher Pharmaceuticals membukukan laba bersih Q2 2026 sebesar USD 4 juta, turun 32% dari setahun sebelumnya; EPS dasar USD 0,16, turun 30%.
Revenue Q2 2026 turun 10% menjadi USD 12,1 juta, dipicu penurunan revenue Natroba 19% menjadi USD 6,3 juta.
Adjusted EBITDA (non-IFRS) Q2 2026 melemah 10% menjadi USD 6,8 juta; margin kotor turun 1 poin persentase menjadi 80%.
Segmen Kanada naik, dengan revenue portofolio Kanada tumbuh 12% menjadi USD 4,6 juta; penjualan Epuris naik 14% menjadi USD 4,1 juta.
Manajemen menargetkan perbaikan kinerja Natroba pada kuartal berikutnya, didukung program stok agar Natroba tersedia di Walmart AS.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cipher Pharmaceuticals Inc. published the original content used to generate this news brief on August 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Cipher net income drops 32% to US$ 4 juta in Q2 FY26; revenue falls 10% to US$ 12,1 juta

You may also like

Crypto prices